Patent classifications
C07K17/10
CARRIER FOR IMMOBILIZING PROTEIN AND PREPARATION METHOD THEREFOR
A SpyCatcher peptide-modified carrier, a protein immobilizing carrier, and a protein immobilizing method. The method comprises: linking a SpyCatcher peptide to a carrier so as to obtain a SpyCatcher peptide-modified carrier; and then based on a SpyCatcher-SpyTag reaction, immobilizing a target protein containing SpyTag to the SpyCatcher-modified carrier. A protein immobilization process in which the method is used is fast, a condition is mild, no extra chemical reagent is needed, the immobilization efficiency and an activity recovery rate are high, and the homogeneity is good.
Starch-based double-loaded functional nano particle as well as preparation method and application
The preparation method of a starch-based double-loaded functional nanoparticle includes: performing restrictive hydrolysis treatment on egg high-density lipoprotein using proteases to obtain the polypeptide; performing self-assembling on a mixed system containing the polypeptide and quercetin under the alkaline condition to form a micelle nanoparticle; performing covalent grafting reaction on a mixed system containing the micelle nanoparticle and anthocyanin under the alkaline condition to form a graft; and electrostatically compounding carboxymethyl dextrin with the graft to obtain the starch-based double-loaded functional nanoparticle. In the preparation method, raw materials derived from natural sources are used, and the self-assembled colloid nanoparticle with good properties can be obtained by adjusting the pH without any organic reagents. The obtained product has a nanoparticle size, has high antioxidant activity and stability against environmental stress, and can be widely applied to the fields of delivery of nutrients, stabilization of biologically active substances and the like.
Functionalizing biological substrates with bioengineered peptides to bind targeted molecules
Method of removing or adsorbing a target substance or material, for example a metal, non-metal toxin, dye, or small molecule drug), from solution by functionalizing a substrate with a peptide configured to selectively bind to the target substance or material and to bind to the substrate. Methods herein are useful for example for biomining applications. More specifically, the method employs metal-binding peptides to remove metals from solution, particularly aqueous solution. More specifically, the substrate is fungal mycelium. Fusion peptides and/or proteins containing metal-binding domain sequence and optionally containing substrate-binding domain sequence are provided. Fusion peptides/proteins containing a metal-binding domain and a chitin-binding domain are provided. Also provided are nucleic acids encoding fusion peptides and/or proteins containing metal-binding domain sequence and those further containing a substrate-binding domain, for example a carbohydrate-binding domain, and more specifically a chitin-binding domain.
Functionalizing biological substrates with bioengineered peptides to bind targeted molecules
Method of removing or adsorbing a target substance or material, for example a metal, non-metal toxin, dye, or small molecule drug), from solution by functionalizing a substrate with a peptide configured to selectively bind to the target substance or material and to bind to the substrate. Methods herein are useful for example for biomining applications. More specifically, the method employs metal-binding peptides to remove metals from solution, particularly aqueous solution. More specifically, the substrate is fungal mycelium. Fusion peptides and/or proteins containing metal-binding domain sequence and optionally containing substrate-binding domain sequence are provided. Fusion peptides/proteins containing a metal-binding domain and a chitin-binding domain are provided. Also provided are nucleic acids encoding fusion peptides and/or proteins containing metal-binding domain sequence and those further containing a substrate-binding domain, for example a carbohydrate-binding domain, and more specifically a chitin-binding domain.
Antibody specific for CD22 and methods of use thereof
The present disclosure provides antibodies specific for an epitope present on CD22. The antibodies are useful in various treatment, diagnostic, and monitoring applications, which are also provided.
Antibody specific for CD22 and methods of use thereof
The present disclosure provides antibodies specific for an epitope present on CD22. The antibodies are useful in various treatment, diagnostic, and monitoring applications, which are also provided.
LIGAND IMMOBILIZATION METHOD
A method for immobilizing a ligand on a formyl group-containing insoluble base material includes producing an imine by mixing the ligand and the formyl group-containing insoluble base material, and reducing the imine by using a borane complex, wherein the ligand comprises an amino group and has a specific affinity for a target compound, and wherein the borane complex has a Lewis base ligand having pK.sub.a of 6.5 or less.
LIGAND IMMOBILIZATION METHOD
A method for immobilizing a ligand on a formyl group-containing insoluble base material includes producing an imine by mixing the ligand and the formyl group-containing insoluble base material, and reducing the imine by using a borane complex, wherein the ligand comprises an amino group and has a specific affinity for a target compound, and wherein the borane complex has a Lewis base ligand having pK.sub.a of 6.5 or less.
Peptide Conjugated Hydrogel Substrate for the Maintenance and Expansion of Human Pluripotent Stem Cells
Compositions useful for propagation of pluripotent stem cells are provided. The compositions comprise a polysaccharide hydrogel linked to a peptide fragment of the extracellular domain of epithelial cadherin. Methods of making the composition, and culturing pluripotent stem cells also are provided.
METHODS AND DEVICES FOR REMOVAL OF IMMUNOSUPPRESSIVE LIGANDS
The present disclosure relates to methods of removing soluble NKG2D ligands, including soluble MICA, soluble MICB and soluble ULBP proteins, from blood to treat diseases characterized by abnormal levels of soluble NKG2D ligands. Further provided are systems and devices for carrying out the therapeutic methods.